share_log

科前生物(688526.SH):主营产品为猪用疫苗,营业收入约95%来源于猪用疫苗的销售

Keqian Biology (688526.SH): The main product is pig vaccine, and about 95% of revenue comes from the sale of pig vaccine

Gelonghui Finance ·  Sep 11, 2023 09:03

Gelonghui September 11?Prefamily biology (688526.SH)According to the investor interactive platform, the company's main products are pig vaccines, and about 95% of its revenue comes from the sales of pig vaccines. In terms of poultry vaccine, the company has also completed the product layout, and continued to increase product research and development and sales work, a number of new product research and development is progressing smoothly, chicken Newcastle disease, avian influenza (subtype H9), infectious bursal disease, avian adenovirus disease (group I, type 4) quadruple inactivated vaccine (LaSota strain + HB01 strain + rVP2+rFiber2) has completed the relevant trials and material supplement as required, and has submitted the registration application and accepted again.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment